NASDAQ:FONR - Fonar Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started $21.11 -0.41 (-1.91 %) (As of 01/23/2019 04:00 PM ET)Previous Close$21.52Today's Range$21.05 - $22.1152-Week Range$19.63 - $30.10Volume12,900 shsAverage Volume19,987 shsMarket Capitalization$134.22 millionP/E Ratio7.00Dividend YieldN/ABeta1.03 ProfileDiscussionChartEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email FONAR Corporation, together with its subsidiaries, operates as a magnetic resonance imaging (MRI) company primarily in the Unites States. It is involved in the research, development, production, and marketing of medical scanning equipment, which uses principles of MRI for the detection and diagnosis of human diseases, abnormalities, other medical conditions, and injuries. The company operates in two segments, Manufacturing and Servicing of Medical Equipment, and Management of Diagnostic Imaging Centers. It provides Upright MRI scanner that allows patients to be scanned in weight-bearing conditions, such as standing, sitting, bending, or lying down. The company markets its scanners to private diagnostic imaging centers and hospitals. It also provides non-medical management services, including development, administration, office space leasing, facilities, equipment, supplies, staffing, credentialing, accounting, billing and collection, assistance with compliance matters, and practice growth and marketing strategies development and implementation services, as well as engages in the training and supervision of non-medical personnel for diagnostic imaging facilities. The company also exports its products to the United Arab Emirates, Switzerland, Canada, England, Germany, and Puerto Rico. It owns and operates 4 diagnostic imaging facilities in Florida; and manages 26 MRI scanning facilities, including 19 facilities located in New York and 7 situated in Florida. The company was founded in 1978 and is based in Melville, New York. Receive FONR News and Ratings via Email Sign-up to receive the latest news and ratings for FONR and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange NASDAQ Industry Electromedical equipment Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:FONR Previous Symbol CUSIPN/A Webwww.fonar.com Phone631-694-2929Debt Debt-to-Equity RatioN/A Current Ratio5.99 Quick Ratio5.85Price-To-Earnings Trailing P/E Ratio7.00 Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales$81.52 million Price / Sales1.65 Cash Flow$3.6459 per share Price / Cash Flow5.79 Book Value$16.26 per share Price / Book1.30Profitability EPS (Most Recent Fiscal Year)N/A Net Income$21.23 million Net Margins23.56% Return on Equity20.53% Return on Assets17.86%Miscellaneous Employees525 Outstanding Shares6,358,000Market Cap$134.22 million OptionableNot Optionable Fonar (NASDAQ:FONR) Frequently Asked Questions What is Fonar's stock symbol? Fonar trades on the NASDAQ under the ticker symbol "FONR." How were Fonar's earnings last quarter? Fonar Co. (NASDAQ:FONR) released its quarterly earnings data on Thursday, November, 8th. The medical equipment provider reported $0.48 EPS for the quarter. The medical equipment provider had revenue of $20.71 million for the quarter. Fonar had a net margin of 23.56% and a return on equity of 20.53%. View Fonar's Earnings History. When is Fonar's next earnings date? Fonar is scheduled to release their next quarterly earnings announcement on Monday, February 11th 2019. View Earnings Estimates for Fonar. Has Fonar been receiving favorable news coverage? News headlines about FONR stock have been trending positive recently, InfoTrie Sentiment reports. The research group identifies positive and negative press coverage by monitoring more than six thousand blog and news sources in real-time. The firm ranks coverage of companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Fonar earned a coverage optimism score of 2.8 on InfoTrie's scale. They also gave news headlines about the medical equipment provider a news buzz of 2.0 out of 10, indicating that recent press coverage is very unlikely to have an impact on the company's share price in the next several days. Who are some of Fonar's key competitors? Some companies that are related to Fonar include Semler Scientific (SMLR), BioLife Solutions (BLFS), Cutera (CUTR), Rockwell Medical (RMTI), Electrocore (ECOR), Zynex (ZYXI), Edap Tms (EDAP), Biosig Technologies (BSGM), Stereotaxis (STXS), IRIDEX (IRIX), Second Sight Medical Products (EYES), Viveve Medical (VIVE), Soleno Therapeutics (SLNO), Digirad (DRAD) and Precision Optics (PEYE). Who are Fonar's key executives? Fonar's management team includes the folowing people: Dr. Raymond V. Damadian, Chairman, Principal Financial Officer & Treasurer (Age 83)Mr. Timothy R. Damadian, CEO & Pres (Age 55)Mr. Luciano B. Bonanni, COO & Exec. VP (Age 64)Ms. Claudette J. V. Chan, Sec. & Director (Age 81)Mr. Daniel Culver, Director of Communications Who are Fonar's major shareholders? Fonar's stock is owned by many different of retail and institutional investors. Top institutional investors include Bowling Portfolio Management LLC (0.65%) and Meeder Asset Management Inc. (0.06%). Company insiders that own Fonar stock include Raymond V Damadian and Robert J Janoff. View Institutional Ownership Trends for Fonar. Which institutional investors are selling Fonar stock? FONR stock was sold by a variety of institutional investors in the last quarter, including Bowling Portfolio Management LLC. Company insiders that have sold Fonar company stock in the last year include Raymond V Damadian and Robert J Janoff. View Insider Buying and Selling for Fonar. Which institutional investors are buying Fonar stock? FONR stock was bought by a variety of institutional investors in the last quarter, including Meeder Asset Management Inc.. View Insider Buying and Selling for Fonar. How do I buy shares of Fonar? Shares of FONR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is Fonar's stock price today? One share of FONR stock can currently be purchased for approximately $21.11. How big of a company is Fonar? Fonar has a market capitalization of $134.22 million and generates $81.52 million in revenue each year. Fonar employs 525 workers across the globe. What is Fonar's official website? The official website for Fonar is http://www.fonar.com. How can I contact Fonar? Fonar's mailing address is 110 Marcus Drive, Melville NY, 11747. The medical equipment provider can be reached via phone at 631-694-2929 or via email at [email protected] MarketBeat Community Rating for Fonar (NASDAQ FONR)Community Ranking: 2.6 out of 5 ( )Outperform Votes: 94 (Vote Outperform)Underperform Votes: 88 (Vote Underperform)Total Votes: 182MarketBeat's community ratings are surveys of what our community members think about Fonar and other stocks. Vote "Outperform" if you believe FONR will outperform the S&P 500 over the long term. Vote "Underperform" if you believe FONR will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 1/23/2019 by MarketBeat.com StaffFeatured Article: How are the companies in the S&P 500 selected?